Clinical Trial Update: Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling [Phase 2]

View source ↗

Summary

This is a Phase 2 pilot study evaluating whether gene expression profiling can predict chemotherapy response in advanced non-small cell lung cancer, which has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED